This company has been marked as potentially delisted and may not be actively trading. NYSE:NPD (NPD) (NPD) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About (NPD) Stock (NYSE:NPD) 30 days 90 days 365 days Advanced Chart Get (NPD) alerts:Sign Up Key Stats Today's Range$2.55▼$2.5550-Day Range N/A52-Week Range$2.00▼$2.59VolumeN/AAverage Volume61,544 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewChina Nepstar Chain Drugstore Ltd. is a retail drugstore chain in China. The Company provides its customers with pharmacy services and a range of other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products, including consumable, seasonal and promotional items. The Company operates through the retail drugstore business segment. The Company also offers private label products. It has a network of approximately 1,990 directly operated drugstores spanning over 70 cities across approximately 14 provinces and direct-controlled municipalities in China. The Company offers approximately 2,170 private label products. The Company also operates an Internet Website, www.star365.com. It offers approximately 3,210 prescription drugs. It offers approximately 3,360 over-the-counter drugs, including western medicines and traditional Chinese medicines, for the treatment of common diseases.Read More… Receive NPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (NPD) and its competitors with MarketBeat's FREE daily newsletter. Email Address NPD Stock News Headlines“Norwich needs heroes:” NPD’s Steve Callender promoted to sergeantApril 25 at 7:05 AM | yahoo.comNPD: Man dead after Granby St. crashApril 19, 2025 | msn.comM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big change. Make America Wealthy Again (M.A.W.A).April 26, 2025 | Paradigm Press (Ad)NPD: Injuries reported after vehicle crash on Granby StreetApril 18, 2025 | yahoo.com2-vehicle crash leaves 1 dead, 3 others injured in NoblesvilleApril 17, 2025 | msn.comNatchitoches police arrest suspects for 2024 homicide on Lakeview DriveApril 17, 2025 | msn.comWoman dies after being struck by vehicle in Norfolk crashApril 17, 2025 | msn.comSuspects arrested for homicide on Lakeview Drive in NatchitochesApril 17, 2025 | msn.comSee More Headlines NPD Stock Analysis - Frequently Asked Questions How were (NPD)'s earnings last quarter? (NPD) (NYSE:NPD) released its quarterly earnings results on Wednesday, November, 25th. The company reported $0.00 earnings per share (EPS) for the quarter. The company had revenue of $124.77 million for the quarter. What other stocks do shareholders of (NPD) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (NPD) investors own include Barrick Gold (GOLD), Inovio Pharmaceuticals (INO), Avid Bioservices (CDMO), Corcept Therapeutics (CORT), Cardiome Pharma (CRME), CTI BioPharma (CTIC) and Sprott Focus Trust (FUND). Company Calendar Last Earnings11/25/2015Today4/26/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:NPD CIK1414850 WebN/A Phone+86-755-26435319FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NYSE:NPD) was last updated on 4/26/2025 by MarketBeat.com Staff From Our Partners2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (NPD) Please log in to your account or sign up in order to add this asset to your watchlist. Share (NPD) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.